Wednesday, June 1, 2016

CORRECTED-BRIEF-Nektar Therapeutics, Daiichi Sankyo Europe sign licensing deal for breast cancer drug

… to
treat patients with advanced breast cancer and brain metastases
Source text …
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)